Association for Japan Health Food Certified
JHFC
← Back to Resources

Collagen: Labeling Standards and Cross-Border Regulatory Compliance

---

Executive Summary

Collagen is among the world's best-selling dietary supplement ingredients. Japan has established a leading position in product development, raw material standardization, and regulatory compliance frameworks for this category. However, because regulatory regimes governing health foods differ substantially across jurisdictions, and because cross-border e-commerce purchasing has become widespread, consumers face a significant information gap when attempting to interpret product labeling, understand ingredient quantity declarations, and recognize compliance marks. This paper systematically examines current rules in Japan and select markets across three dimensions—ingredient quantity labeling standards, label compliance requirements, and cross-border purchase compliance—with the aim of providing consumers with an objective, actionable reference framework.

---

1. Regulatory Classification of Collagen Health Foods

1.1 Japan's Legal Framework

In Japan, orally consumed products containing collagen circulate overwhelmingly as food, regulated under the Food Sanitation Act, the Health Promotion Act, and the Act against Unjustifiable Premiums and Misleading Representations (the Premiums and Representations Act).

The Ministry of Health, Labour and Welfare (MHLW) and the Consumer Affairs Agency (CAA) are the principal regulatory authorities. Products designated as "Functionally Labeled Food" must submit pre-market notification materials to the CAA—including a systematic review (SR) of the relevant literature or results from randomized controlled trials (RCTs)—and must carry a label statement to the effect that "this claim is made under the responsibility of the business operator." Products sold as ordinary food or general nutritional supplements may not include any language on their labels or in their advertising that implies disease prevention or amelioration.

The critical boundary: Regardless of product category, orally consumed collagen products may not claim to treat, diagnose, or prevent any disease. Making such claims constitutes a violation of the Pharmaceuticals and Medical Devices Act (PMDA Act).

1.2 Comparison with China's Regulatory Framework

China employs a dual-track system of registration and filing for health foods, requiring the Blue Hat mark issued by the State Administration for Market Regulation (SAMR) before a product may be sold in China as a health food. Products that hold only a domestic sales qualification—without Blue Hat registration or filing—may not be marketed or sold within China as "health food"; doing so constitutes a regulatory violation. Importing a product as ordinary food requires compliance with China's national food safety standards, including restrictions on ingredient types and additive categories. Regulatory compliance in Japan does not automatically confer compliance in China.

---

2. Ingredient Quantity Labeling Standards for Collagen Products

2.1 Labeling Distinctions: "Collagen Peptides" vs. "Collagen"

Collagen products available on the market fall into three principal raw material categories:

FormMolecular Weight RangeCommon Label Designation
Native (unhydrolyzed) collagen>100,000 DaCollagen
Collagen peptides (hydrolyzate)1,000–10,000 DaCollagen Peptide
Low-molecular-weight collagen peptides<1,000 DaLow-molecular-weight collagen

Japan currently has no mandatory national standard governing the molecular weight range for "collagen peptides." However, industry bodies such as the Japan Gelatin & Collagen Industrial Association have issued voluntary guidelines requiring that products making claims about specific molecular weights be supported by verifiable test data. Consumers should check whether a product publicly discloses specific molecular weight values and the analytical methods used to determine them.

2.2 Labeling Requirements for Daily Intake and Ingredient Quantities

Under Japan's Food Labeling Standards (established 2015, subsequently amended), processed food labels must state both the per-serving reference intake and the daily reference intake, with the contents of principal ingredients listed correspondingly.

For Functionally Labeled Foods, the CAA imposes additional requirements:

Consumer identification tip: A product that lists only "Collagen × g per serving" without specifying peptide form or molecular weight provides limited transparency. Products that disclose amino acid scores, peptide content assay results, or the source of their test reports offer comparatively higher informational reliability.

2.3 Labeling of Raw Material Origin and Source Species

The primary raw material sources for collagen are porcine skin, bovine hide and bone, and fish scales and skin. Japan's Food Labeling Standards impose country-of-origin declaration obligations for raw materials, though specific requirements vary by product category:

---

3. Core Label Compliance Requirements

3.1 Prohibited Statement Categories

Under the Premiums and Representations Act and the CAA's guidance on health food advertising, the following statement types are non-compliant or represent high-risk areas:

3.2 Mandatory Label Elements

Under the Food Labeling Standards, processed food labels must include the following mandatory items:

3.3 GMP Certification and Third-Party Testing

The Japan Health and Nutrition Food Association (JHNFA) operates a GMP Compliance Certification program, auditing manufacturing facilities on raw material management, production processes, finished-product testing, and shipment controls. Certification numbers (e.g., Certification No. 34225) are publicly verifiable identifiers. Certification indicates that a facility's manufacturing processes have undergone third-party audit and that a degree of traceability assurance is in place; it does not, however, constitute endorsement of any product's efficacy.

Consumers can visit the JHNFA's official website and search by certification number to confirm whether a certification is currently active and whether the registered facility matches the stated product manufacturer. This is the most direct method available for verifying a product's manufacturing compliance.

---

4. Cross-Border Purchase Compliance

4.1 Personal Import Quantity Limits: Hand-Carry and Mail Order

Under customs regulations, health foods imported for personal use—whether hand-carried or ordered by individuals through international mail—are exempt from duty on goods with a total retail value in Japan of up to JPY 200,000 (certain categories were adjusted in the 2024 revision), provided the quantities are consistent with "reasonable personal use." Quantities exceeding this threshold, or evidence of resale intent, may result in classification as a commercial import, requiring customs declaration and tariff payment in the destination country.

4.2 Regulatory Requirements for Import into China

Importing health foods into mainland China requires attention to the following key compliance points:

(i) Import as Ordinary Food

Where a product holds only ordinary food status (no Blue Hat), it may be imported as ordinary food, subject to compliance with China's national food safety standards:

(ii) Import as Health Food

Selling a product in China as "health food" requires a registration application to SAMR (imported health foods must obtain an approval registration number), involving ingredient safety assessments, functional testing, and label review. The process is typically lengthy. Marketing a product as health food without a valid approval number violates the Measures for the Registration and Filing Administration of Health Foods.

(iii) Cross-Border E-Commerce Channel

health foods purchased through cross-border e-commerce platforms (such as Tmall Global or JD International) are subject to interim regulations governing cross-border e-commerce and are classified as "personal import goods." These products are exempt from the health food registration requirement, but the platform must complete its own qualification filing, and consumers must sign a personal liability acknowledgment. Under this channel, -language labeling is not required; however, consumers assume the associated risks themselves, and such goods are not eligible for consumer protections applicable to registered health foods.

4.3 Variations Across Taiwan, Hong Kong, and Singapore

---

5. Consumer Action Checklist

Based on the compliance framework set out above, consumers evaluating collagen health food products should refer to the following checklist:

1. Verify completeness of mandatory label elements.

A legitimate product label should include, at minimum: manufacturer's name and address, best-before date, storage instructions, ingredient list (including additives), and a nutrition facts panel. Incomplete labeling warrants heightened scrutiny.

2. Identify the product's regulatory category.

Check whether the product is designated as Functionally Labeled Food, Food for Specified Health Uses (FOSHU), or ordinary food. Notification details for Functionally Labeled Foods can be searched in the CAA's publicly accessible database, allowing consumers to verify that the product name and functional claims on the label are consistent with the filed records.

3. Assess ingredient quantity disclosure.

Prefer products that declare collagen (peptide) content per daily serving over those that merely note "contains collagen" without quantity. Products that also disclose molecular weight values and analytical methods offer a higher level of information transparency.

4. Verify GMP manufacturing certification.

If a product claims JHNFA GMP Compliance Certification, use the certification number to search the JHNFA official website and confirm that the certification is currently active and that the certified facility corresponds to the product's stated manufacturer.

5. Confirm destination-market compliance before cross-border purchase.

If the product will be hand-carried to or shipped to mainland China, confirm that the quantity falls within the reasonable personal-use limit and familiarize yourself with the destination market's admissibility rules for the relevant ingredients. Cross-border e-commerce and general trade channels operate under different regulatory regimes; consumers should be clear about which channel applies to their purchase.

6. Maintain appropriate skepticism toward exaggerated promotional claims.

Any claim describing specific outcomes—such as "skin improved after use" or "joint recovery"—falls outside the scope of permissible health food representations under regulations. Upon encountering such claims, verify whether the product holds the relevant regulatory qualifications and whether the claim originates from the manufacturer's official communications.

---

Conclusion

Labeling compliance for collagen health foods is a multifaceted issue that cuts across food regulation, advertising law, and cross-border trade. Japan has established a relatively mature, tiered regulatory framework in this area, encompassing pre-market notification for Functionally Labeled Foods and GMP manufacturing certification—both of which provide publicly verifiable information sources. For consumers, understanding the logic of this framework—what information is legally mandated, what falls under voluntary industry standards, and where the compliance boundaries lie—offers more durable guidance than reliance on any single brand's endorsements.

Cross-border purchasing adds further complexity. Destination markets differ materially in their requirements for market entry, labeling, and permitted ingredient lists: "legally sold in Japan" does not mean "globally compliant." When making purchasing decisions, consumers who factor in product label transparency, the verifiability of manufacturing certifications, and the admissibility rules of their destination market are taking a practical approach to managing compliance risk.

---

*The information in this document reflects the regulatory position as of June 2026. Where regulations have been subsequently updated, the relevant official publications take precedence. This document does not constitute legal advice and does not constitute medical advice of any kind.*

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources